CLINICAL_TRIALS
trial_result
· 2018-02-15
Clinical Trial Update: Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis [Phase 2]
Summary
Phase 2a study completed evaluating the efficacy and safety of MEDI9929 in adults with atopic dermatitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: MedImmune LLC | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2018-02-15